ΰµÂÌåÓý_ÖйúÌå²ÊÍø-²ÊƱ|Ͷע

Ò©Îﻯѧѧ¿ÆÒÀÍÐÓÚÒ©Îﻯѧ½ÌÑÐÊÒ£¬½ÌÑÐÊÒÓÉÒ©Îﻯѧ¡¢ÌìȻҩÎﻯѧºÍÓлú»¯Ñ§ÈýÃÅѧ¿Æ×é³É£¬ËùÊôµÄ¸÷ѧ¿Æ³ÉÁ¢ÓÚ1976Äê11Ô¡£2009ÄêÒòѧ¿Æ½¨ÉèºÍ¹ÜÀí¹¤×÷µÄÐèÒª×齨ΪÓлúÒ©»¯¡¢ÌìȻҩ»¯½ÌÑÐÊÒ£¬2013Äê¸üÃûΪҩÎﻯѧ½ÌÑÐÊÒ¡£Ò©Îﻯѧ½ÌÑÐÊÒÖ÷Òª³Ðµ£Ò©Îﻯѧ¡¢ÌìȻҩÎﻯѧ¡¢Óлú»¯Ñ§¡¢Ò½Óûù´¡»¯Ñ§£¨2£©¡¢Óлú»¯ºÏÎï½á¹¹½âÎöºÍÐÂÒ©Ñо¿Ó뿪·¢µÈ¿Î³ÌµÄ½ÌѧÈÎÎñ¡£

Ä¿Ç°±¾½ÌÑÐÊÒ¹²ÓнÌʦ20Ãû£¬ÆäÖоßÓв©Ê¿Ñ§Î»µÄÕ¼85%£¬¾ßÓи߼¶Ö°³ÆµÄÕ¼65%£¬Ë¶Ê¿Éúµ¼Ê¦16Ãû¡£

2020~2022ÄêÆڼ䣬±¾½ÌÑÐÊÒ½Ìʦ¹²Ö÷³ÖÁË1ÏîÊ¡²¿¼¶½Ì¸Ä¿ÎÌâ¡£½ü3ÄêÖ÷³Ö¿ÆÑпÎÌâ10ÏÆäÖйú¼Ò¼¶4Ïʡ²¿¼¶6ÏÀۼƿÆÑо­·Ñ260ÓàÍòÔª£¬»ñÊÚȨ·¢Ã÷רÀû16Ïî¡£ÒÔµÚÒ»×÷Õß»òͨѶ×÷Õß·¢±íµÄ¿ÆÑÐÂÛÎÄ50Óàƪ£¬ÆäÖÐSCIÊÕ¼ÂÛÎÄ40ƪ¡£

Ò»¡¢½ÌѧÇé¿ö

£¨Ò»£©½üÈýÄê³Ðµ£µÄ½Ì¸ÄÏîÄ¿

Àî·¼Ò«£¬Ò©Ñ§×¨ÒµË¶Ê¿Ñо¿Éú¸ßµÈÓлú»¯Ñ§»ìºÏʽ½ÌѧģʽµÄÑо¿Óëʵ¼ù£¬¹ãÎ÷½ÌÓýÌü£¬2022Äê¡£

£¨¶þ£©½üÈýÄê»ñµÃµÄ½Ìѧ³É¹û½±

ÑîÑÅÅÃûÇ°4£©£¬¡°²ú½ÌÈÚºÏ,ÐÐÒµÇý¶¯¡±¹¹½¨µØ·½Ò½Ò©ÔºÐ£Ò©Ñ§Ò»Á÷רҵÈ˲ÅÅàÑøÐÂģʽ£¬¹ãÎ÷¸ßµÈ½ÌÓýΰµÂÌåÓý_ÖйúÌå²ÊÍø-²ÊƱ|Ͷע¼¶½Ìѧ³É¹û½±Ò»µÈµÈ´Î£¬2021Äê¡£

¶þ¡¢¿ÆÑÐÇé¿ö

£¨Ò»£©½ÌÑÐÊÒÖ÷ÒªÑо¿·½Ïò

ÐÂÒ©·Ö×ÓµÄÉè¼ÆÓëºÏ³É£»ÌìȻҩÎï»îÐԳɷֵÄÑо¿ºÍ½á¹¹¸ÄÔ죻ÊÖÐÔ´ß»¯¼ÁµÄÑо¿£»Ò©ÎïºÏ³É·½·¨Ñ§

£¨¶þ£©½üÈýÄê³Ðµ£µÄ¿ÆÑÐÏîÄ¿

1.ÕÅÒµ£¬°ÐÏòIDO1/STAT3µÄ1,4-ÝÁõ«²¬(IV)½ðÊô»¯Ñ§ÃâÒßÖÎÁƼÁµÄÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2021Äê¡£

2.»ÆÈÕÕò£¬ÐÂÐÍ1,4-ÝÁõ«ë¿ÀàIDO1/STAT3Ë«°ÐµãÒÖÖƼÁµÄÉè¼Æ¡¢ºÏ³É¼°¿¹Ö×Áö»îÐÔÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ð£¬2021Äê¡£

3.Ì·ÇÕ¸Õ£¬»ùÓÚ´úл×éѧµÄ׳ҩÂçʯÌÙ¿¹RAҩЧÎïÖÊ»ù´¡¼°×÷ÓûúÖÆÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2020Äê¡£

4.Ì·Ïà¶Ë£¬ÐÂÐÍFXR²¿·Ö¼¤¶¯¼ÁµÄÉè¼ÆºÏ³É¼°¿¹·Ç¾Æ¾«ÐÔÖ¬·¾ÐÔ¸ÎÑ×»îÐÔÑо¿£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2020Äê¡£

5.ÕÅÒµ£¬°ÐÏòIDO1/STAT3µÄ1,4-ÝÁõ«-²¬½ðÊô»ùÖ×Áö»¯Ñ§ÃâÒßÖÎÁƼÁ£ºÉè¼ÆºÏ³É¡¢»îÐÔÓë×÷ÓûúÖÆÑо¿£¬¹ãÎ÷½Ü³öÇàÄê»ù½ð£¬2020Äê¡£

6.ÕÅÒµ£¬»ùÓÚ°ÐÏòÔØËÍ-Ç°Ò©²ßÂÔÉè¼ÆºÏ³É¡°¾ÛÒÒ¶þ´¼-°ÐÏòëÄ-ÒÁÁ¢Ì濵¡±¿¹Ö×Áö»¯ºÏÎïµÄÑо¿£¬¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð£¬2020Äê¡£

7.ÂíСÅΣ¬2-È¡´úßÅßῪ»·²ßÂԺϳÉÖáÊÖÐÔà­à¸ßø»¯ºÏÎ¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð£¬2020Äê¡£

Ī×æìÏ£¬µç»¯Ñ§½éµ¼C(sp3)-H¼ü»Çõ£»¯µÄÑо¿£¬¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð£¬2020Äê¡£

8.ÕÅæ¤æ¤£¬OsimertinibÑÜÉúÎïµÄ½á¹¹Éè¼Æ¡¢ºÏ³É¼°¿¹Ö×Áö»îÐÔÑо¿£¬¹ãÎ÷¿Æ¼¼»ùµØºÍÈ˲ÅרÏ2020Äê¡£

9.»ÆÈÕÕò£¬ÐÂÐÍÃâÒß-»¯Áƹ¦ÄÜÒ»Ì廯µÄIDO1/STAT3ÒÖÖƼÁÑо¿£¬¹ãÎ÷¿Æ¼¼»ùµØºÍÈ˲ÅרÏ2020Äê¡£

£¨Èý£©½üÈýÄê´ú±íÐÔÂÛÎÄ

1.Electrochemicallymediateddirect C(sp³)?H Sulfonylation ofxanthenederivatives.Adv Synth Catal,2022, 364(4): 726-731. (Ī×æìÏ£¬Í¨Ñ¶×÷Õߣ©

2.Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity. Arab J Chem, 2022,15: 104145.£¨Àî·¼Ò«£¬Í¨Ñ¶×÷Õߣ©

3.Synthesis and biological evaluation of novel pentanediamide derivatives as S-adenosyl-L-homocysteine hydrolase inhibitors. Bioorg Med Chem Lett,2022, 72: 128880.£¨Ì·Ïà¶Ë,ͨѶ×÷Õߣ©

4.Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor¦Ãt inverse agonists. Eur J Med Chem, 2022, 229:114065.£¨»ÆÈÕÕò£¬Í¨Ñ¶×÷Õߣ©

5.Visible-light-induced tandem reaction of allenes with selenesulfonates leading to (E)-2,3-disulfonylpropene derivatives. J Org Chem,2022, 87:5846-5855. (³ÂÑÞÑÞ£¬Í¨Ñ¶×÷Õß)

6.Structures and biological activities of polyacylated ent-kaurane diterpenoid glycosides from the aerial parts of Inula hupehensis. J Nat Prod, 2022, 85:185-195.(ÕŹó½Ü£¬Í¨Ñ¶×÷Õß)

7.Anti-inflammatory constituents from Caulis Trachelospermi.Planta Med,2022, 88(9-10): 721-728.(Ì·ÇÕ¸Õ£¬Í¨Ñ¶×÷Õß)

8.Dimeric Erythrinaalkaloids as well as their key units from Erythrina variegate.Phytochemistry,2022, 198: 113160.(Ì·ÇÕ¸Õ£¬Í¨Ñ¶×÷Õß)

9.Synthesis of new chlorins photosensitizer for photodynamic therapy against colon cancer. Mater Chem Front, 2022, 6: 1129-1136.£¨×޵Ƿ壬ͨѶ×÷Õߣ©

10.A tricomponent semiconducting polymer with ultrahigh photothermal conversion efficiency as a biodegradable photosensitizer for phototheranostics. Mater Chem Front. 2022, 6: 8-14.£¨×޵Ƿ壬ͨѶ×÷Õߣ©

11.Visible light-promoted selenylation/cyclization of enaminones toward the formation of 3-selanyl-4H-chromen-4-ones. Adv Synth Catal, 2021, 363:1656-1661.£¨ÐìÑàÀö£¬Í¨Ñ¶×÷Õߣ©

12.Synthesis of indolo[2,1-a]isoquinolin-6(5H)-ones derivatives via Fe(OTf)3-promoted tandem selenylation/cyclization of 2-arylindoles. Adv Synth Catal, 2021, 363:497-504.(ÐìÑàÀö£¬Í¨Ñ¶×÷Õß)

13.Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA. Eur J MedChem, 2021, 210:112951.(ÕÅÒµ£¬Í¨Ñ¶×÷Õß)

14.Visible-lght-induced cyclization/aromatization of 2-vinyloxy arylalkynes: synthesis of thio-substituted dibenzofuran derivatives. Org Lett, 2021, 23:376-381.(³ÂÑÞÑÞ£¬Í¨Ñ¶×÷Õß)

15.Visible-light-induced radical cascade reaction of 1-allyl-2-ethynylbenzoimidazoles withthiosulfonates to assemble thiosulfonylated pyrrolo[1,2-a]benzimidazoles.J Org Chem, 2021, 86:16882-16891.(³ÂÑÞÑÞ£¬Í¨Ñ¶×÷Õß)

16.Phloroglucinol derivatives rhotomensones A-G from Rhodomyrtus tomentosa. Phytochemistry, 2021, 190:112890.(Áº³ÉÇÕ£¬Í¨Ñ¶×÷Õß)

17.Anti-hepatitis B virus activity and hepatoprotective effect ofdes(rhamnosyl) verbascoside from Lindernia ruellioides in vitro. Phytother Res, 2021, 35(8):4555-4566.£¨Áº³ÉÇÕ£¬Í¨Ñ¶×÷Õߣ©

18.Bioactive dammarane triterpenoid saponins from the leaves of Cyclocarya paliurus. Phytochemistry, 2021, 183:112618.£¨Áº³ÉÇÕ£¬Í¨Ñ¶×÷Õߣ©

19.Designing a lysosome targeting nanomedicine for pH triggered enhanced phototheranostics.Mater Chem Front, 2021, 5:2694-2701.£¨×޵Ƿ壬µÚÒ»×÷Õߣ©

20.A heavy atom free miconducting polymer with high singlet oxygen quantum yield for photodynamic and photothermal synergistic therapy. Mater Design,2021, 109263-109270.£¨×޵Ƿ壬ͨѶ×÷Õߣ©

21.Synthesis and biological evaluation of dehydroabietic acid-pyrimidine hybrids as antitumor agents. RSC Adv, 2020, 10:18008-18015.£¨Àî·¼Ò«£¬Í¨Ñ¶×÷Õߣ©

22.Naturally available hypericin undergoing electron transfer for type I photodynamic and photothermal synergistic therapy. Biomater Sci, 2020, 8£º2481-2487.£¨×޵Ƿ壬ͨѶ×÷Õߣ©

23.Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo. Bioorg Chem,2020, 99:103814-103825.£¨»ÆÍñÔÆ,µÚÒ»×÷Õߣ©

24.Discovery of novel N-aryl pyrrothine derivatives as bacterial RNA polymerase inhibitors. Chem Biol Drug Des, 2020,96:1262¨C1271.£¨Ì·Ïà¶Ë,ͨѶ×÷Õߣ©

25.Synthesis, mechanisms of action, and toxicity of novel aminophosphonates derivatives conjugated irinotecan in vitro and in vivo as potent antitumor agents. Eur J Med Chem, 2020, 189:112067.£¨»ÆÈÕÕò£¬Í¨Ñ¶×÷Õߣ©

26.Potential anti-diabetic isoprenoids and a long-chain¦Ä-lactone from frangipani (Plumeria rubra).Fitoterapia,2020, 146: 104684.(Ì·ÇÕ¸Õ£¬Í¨Ñ¶×÷Õß)

27.Bifunctional naphthoquinone aromatic amide-oxime derivatives exert combined immunotherapeutic and antitumor effects through simultaneous targeting of indoleamine-2,3-dioxygenase and signal transducer and activator of transcription 3. J Med Chem, 2020, 63: 1544?1563.(ÕÅÒµ£¬Í¨Ñ¶×÷Õß)

28.Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents. Eur J Med Chem, 2020, 188:112033.(ÕÅÒµ£¬Í¨Ñ¶×÷Õß)

29.Saponin from Periploca forrestiiSchltr Mitigates oxazolone-induced atopic dermatitis via modulating macrophage activation.Mediators Inflamm, 2020, 2020:4346367.(Ëï¹ã³¼£¬µÚÒ»×÷Õß)

30.Electrochemical sulfonylation of alkynes with sulfonyl hydrazides:ametal- and oxidant- free protocol for the synthesis of alkynyl sulfones. Adv Synth Catal,2020, 362(11): 2160-2167. (Ī×æìÏ£¬µÚÒ»×÷Õߣ©

31.Sesquineolignan and neolignan enantiomers from Triadica sebifera. Bioorg Chem, 2020, 103: 104147. (ÕŹó½Ü£¬Í¨Ñ¶×÷Õß)

£¨ËÄ£©½üÈýÄê»ñµÃרÀûÇé¿ö

1.³ÂÑÞÑÞ£¬ÐìÑàÀö£¬³Â»Û.Ò»ÖֺϳÉ11-Áò»ùÝÁ²¢[2,3-b]±½²¢ß»à«»¯ºÏÎïµÄ·½·¨£ºÖйú£¬×¨ÀûÊÚȨºÅZL202011424026.0,ÊÚȨ¹«¸æÈÕ2022.09.20.

2.Áº³ÉÇÕ£¬ÖÜÏÈÀö£¬ÂÞÇÙ£¬µÈ.´ïÂêÍéÈýÝÆÔíÜÕ»¯ºÏÎï¼°ÆäÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL 20201 1 048083.3,ÊÚȨ¹«¸æÈÕ2021.08.31.

3.×޵Ƿ壬Ö컪£¬¿ÂÕ䣬µÈ.ÒøÐÓÄÚõ¥µÄÌáÈ¡·½·¨£ºÖйú£¬×¨ÀûÊÚȨºÅZL201810438920.X,ÊÚȨ¹«¸æÈÕ2020.9.11.

4.ÐìÑàÀö£¬ÕżÎÈØ£¬³ÂÑÞÑÞ.Ò»ÖֺϳÉ5-Îø»ùßÅßá²¢[2,1-a]Òìà­ßø-6(5H)-ͪ»¯ºÏÎïµÄ·½·¨£ºÖйú£¬×¨ÀûÊÚȨºÅZL 202011168440.X,ÊÚȨ¹«¸æÈÕ2021.07.02.

5.ÕÅÒµ£¬Àî·¼Ò«£¬¶ÎСȺ£¬µÈ.3-±½²¢ßäßò-6,7-ºú½·»·-2(1H)-à­ßøͪ-пÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL2018107295134,ÊÚȨ¹«¸æÈÕ2021.03.02.

6.ÕÅÒµ£¬ÂíÏ×Á¦£¬ÓàÑâ³É£¬µÈ.11,12-¶þÂȱ½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810730055.6,ÊÚȨ¹«¸æÈÕ2020.09.25.

7.ÕÅÒµ£¬ÂíÏ×Á¦£¬ÓàÑâ³É£¬µÈ.11-Èý·ú¼×»ù±½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810729763.8,ÊÚȨ¹«¸æÈÕ2020.09.25.

8.ÕÅÒµ£¬ÂíÏ×Á¦£¬ÓàÑâ³É£¬µÈ. 12-Âȱ½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810729521.9,ÊÚȨ¹«¸æÈÕ2020.09.29.

9.ÕÅÒµ£¬ÓàÑâ³É£¬ÂíÏ×Á¦£¬µÈ.±½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810729771.2,ÊÚȨ¹«¸æÈÕ2020.09.29.

10.ÕÅÒµ£¬ÂíÏ×Á¦£¬ÓàÑâ³É£¬µÈ.11,12-¶þ¼×»ù±½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810730052.2,ÊÚȨ¹«¸æÈÕ2020.09.29.

11.ÕÅÒµ£¬ÂíÏ×Á¦£¬ÓàÑâ³É£¬µÈ.12-·ú±½²¢ßäßò-1,8-ÝÁõ£ÑÇ°·-²¬ÅäºÏÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810730053.7,ÊÚȨ¹«¸æÈÕ2020.09.29.

12.Àî·¼Ò«£¬ÍõÐ㣬ÅÓ¸»»ª£¬µÈ.È¥ÇâèÈËá‡fßòÍéͪÑÜÉúÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201810119381.3,ÊÚȨ¹«¸æÈÕ2021-02-12.

13.»ÆÍñÔÆ£¬ÕÅСÈØ£¬ÂÀÁ¼£¬µÈ.ßÕàº[6,1-b]²¢à­ßòßøͪÑÜÉúÎï¼°ÆäÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201811385851.7,ÊÚȨ¹«¸æÈÕ2021.3.23.

14.»ÆÍñÔÆ£¬ÕÅÏþæã¬Ö£±ò£¬µÈ.5-°±»ù±½²¢[b][1,8]ÝÁà¤À໯ºÏÎïµÄÖƱ¸·½·¨ºÍÓ¦ÓãºÖйú£¬×¨ÀûÊÚȨºÅZL201910698398.3,ÊÚȨ¹«¸æÈÕ2021.8.24.

15.Ì·Ïà¶Ë£¬ÂÀÁ¼£¬ÃɽÜë…£¬µÈ. N-·¼»ù¶þÁòßÁ¿©ÍªëåÀàºÍ°±»ùõ¥ÀàÑÜÉúÎï¼°ÆäÖƱ¸»¯º